Save information for later
Sign Up

Learn About Neurotoxicity Syndromes

What is the definition of Neurotoxicity Syndromes?
Neurotoxicity syndromes is a term used to describe neurological disorders caused by exposure to toxic substances. Neurotoxicity may occur after exposure to substances such as drugs; chemotherapy; radiation; heavy metals, such as lead or mercury; pesticides; industrial and/or cleaning solvents; petroleum-based products and dispersants; some foods and food additives; and some naturally occurring environmental substances. Exposure to such toxic substances disrupts or kills nerve cells, or neurons, that are responsible for brain and nervous system functions. Neurotoxicity may occur by exposure to toxic substances through ingestion, injection, inhalation, spray, direct skin exposure, or other methods.
What are the symptoms of Neurotoxicity Syndromes?
Symptoms of neurotoxicity may be immediate or delayed. Symptoms of neurotoxicity can include weakness, numbness, headache, memory loss, visual disturbances, cognitive difficulties, behavioral changes, and loss of sexual function, among others.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Neurotoxicity Syndromes?
Treatment for neurotoxicity includes stopping any exposure to the toxic substance and supportive therapy to treat the associated symptoms.
Who are the top Neurotoxicity Syndromes Local Doctors?
Family Medicine | Internal Medicine
Family Medicine | Internal Medicine

St Lukes Clinic-Treasure Valley LLC

608 W Hays St, 
Boise, ID 
 0.5 mi
Accepting New Patients

Jennifer Chun-Brodie is a Family Medicine specialist and an Internal Medicine provider in Boise, Idaho. Dr. Chun-Brodie has been practicing medicine for over 15 years and is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. Her top areas of expertise are Sepsis, Necrotizing Enterocolitis, Pseudomembranous Colitis, Endoscopy, and Colonoscopy. Dr. Chun-Brodie is currently accepting new patients.

Family Medicine
Family Medicine

Saint Alphonsus Regional Medical Center Inc

1055 N Curtis Rd, 
Boise, ID 
 2.6 mi

Steven Von Flue is a Family Medicine provider in Boise, Idaho. Dr. Von Flue has been practicing medicine for over 26 years and is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Sepsis, Chronic Inflammatory Response Syndrome (CIRS), H1N1 Influenza, Peptic Ulcer, and Hip Replacement.

 
 
 
 
Learn about our expert tiers
Learn More
Internal Medicine
Internal Medicine

St Lukes Clinic-Treasure Valley LLC

610 W Hays St, 
Boise, ID 
 0.5 mi
Accepting New Patients

Daniel Mcclaskey is an Internal Medicine provider in Boise, Idaho. Dr. Mcclaskey and is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Sepsis, Stroke, Pulmonary Embolism, Endoscopy, and Gastrostomy. Dr. Mcclaskey is currently accepting new patients.

What are the latest Neurotoxicity Syndromes Clinical Trials?
IIT2022-04-Sasine-CAR-T: a Phase 1 Single-arm, Open-label Study to Evaluate the Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells with Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects with Relapsed/Refractory Hematological Malignancies

Summary: The study is designed to examine the feasibility and safety of collecting autologous hematopoietic stem cells (HSCs) to be combined with CAR T-cell therapy for patients with relapsed/refractory (r/r) hematological disease. The study will evaluate feasibility of collecting the target dose of HSCs from at least 50% of enrolled patients. The study will assess safety based on incidence and severity of...

Match to trials
Find the right clinical trials for you in under a minute
Get started
What are the Latest Advances for Neurotoxicity Syndromes?
ABCL-044 Clinical Outcomes of Commercial CD19-Targeted CAR T-Cell Therapy in Patients With Secondary Central Nervous System Lymphoma.
Tired of the same old research?
Check Latest Advances
Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms.